Andrew Lo
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew Lo
Andrew Lo was last confirmed as Board Member at BridgeBio Pharma, Inc. (BBIO) in a filing dated April 30, 2021. Earlier roles on record: Board Member at AbCellera Biologics Inc. (ABCL) until November 10, 2025. AbCellera Biologics Inc. reported in an 8-K filed November 12, 2025 that Andrew Lo resigned as Director, effective November 10, 2025.
“On November 10, 2025, Andrew Lo, Ph.D. resigned from the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-01-01–2025-11-10
-
2021-01-01–2025-11-10
-
Start not stated–2021-04-30
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.